To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer
PHASE2
The purpose of this study is to evaluate the efficacy and safety of Disitam...
A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection
PHASE2
This is a prospective, open label, multicenter clinical study of vediximab ...
Status
Not Yet Recruiting
Location
Renji Hospital, Shanghai Jiaotong University School of Medecine